These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4948086)

  • 21. Streptomycin combined with sulfones in the treatment of relapsed lepromatous leprosy.
    McDougall AC; Hastings RC
    Int J Lepr Other Mycobact Dis; 1968; 36(4):456-7. PubMed ID: 5753815
    [No Abstract]   [Full Text] [Related]  

  • 22. Results of long-term domiciliary dapsone (DDS) monotherapy for lepromatous leprosy in Gudiyatham Taluk, South India.
    Almeida JG; Christian M; Chacko CJ
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):385-6. PubMed ID: 6685703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Should treatment be discontinued in the case of a lepromatous leprosy patient who follows treatment very irregularly?].
    Mugnier P
    Acta Leprol; 1983; 1(2):105-8. PubMed ID: 6356764
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical trial with CIBA 1906 in lepromatous leprosy.
    Anand LC; Tiwari VD; Rathore BS; Singh O
    Lepr India; 1981 Apr; 53(2):278-84. PubMed ID: 7019567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immuno-allergic accidents with rifamipcin].
    Flageul B; Wagner L; Cottenot F
    Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy.
    Paul S; Rose ET
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):342-3. PubMed ID: 7198625
    [No Abstract]   [Full Text] [Related]  

  • 27. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation of Acacia catechu, Willd. (Khadira) in the treatment of lepromatous leprosy.
    Ojha D; Singh G; Upadhyaya YN
    Int J Lepr Other Mycobact Dis; 1969; 37(3):302-7. PubMed ID: 5393205
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter: Low doses of dapsone in the treatment of leprosy.
    Jopling WH
    Int J Lepr Other Mycobact Dis; 1972; 40(4):419. PubMed ID: 4677498
    [No Abstract]   [Full Text] [Related]  

  • 30. Rifampicin (RFP) trial in lepromatous leprosy.
    Koticha KK; Pade SS; Chulawala RG; Juwatkar PS
    Lepr India; 1982 Jul; 54(3):441-7. PubMed ID: 6757577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral zinc as an adjunct to dapsone in lepromatous leprosy.
    Mathur NK; Bumb RA; Mangal HN; Sharma ML
    Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):331-8. PubMed ID: 6541200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dapsone levels after oral therapy and weekly oily injections in Ethiopian leprosy patients.
    Modderman ES; Merkus FW; Zuidema J; Hilbers HW; Warndorff T
    Int J Lepr Other Mycobact Dis; 1983 Jun; 51(2):191-6. PubMed ID: 6684645
    [No Abstract]   [Full Text] [Related]  

  • 33. Long term effects of chemoprophylaxis among contacts of lepromatous cases. Results of 8 1/2 years follow-up.
    Noordeen SK
    Lepr India; 1977 Oct; 49(4):504-9. PubMed ID: 342824
    [No Abstract]   [Full Text] [Related]  

  • 34. [Field experiences with therapy protocols in leprosy].
    Pattyn SR
    Verh K Acad Geneeskd Belg; 1983; 45(3):303-14. PubMed ID: 6364614
    [No Abstract]   [Full Text] [Related]  

  • 35. Follow-up of lepromatous (LL and BL) patients on dapsone (DDS) monotherapy after attainment of smear negativity in Gudiyatham Taluk, South India.
    Almeida JG; Christian M; Chacko CJ
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):382-4. PubMed ID: 6685702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of drug regimen in lepromatous leprosy--II.
    Ramu G; Sreevatsa
    Lepr India; 1983 Apr; 55(2):200-8. PubMed ID: 6195452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [2 cases of paucibacillary leprosy resistant to dapsone].
    Janssens L
    Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intramuscular injection of dapsone in therapy for leprosy: a new approach.
    Modderman ES; Huikeshoven H; Zuidema J; Leiker DL; Merkus FW
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):51-6. PubMed ID: 7061179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative study of the activity of 6 antileprosy drugs].
    Languillon J
    Med Trop (Mars); 1969; 29(6):694-8. PubMed ID: 4927959
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.